Showing results (271-280 of 314) with videos related to

Sort By:
Pageof 32
Health Technology Assessment (Winchester, England)|October 8, 2015
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)Usha Chakravarthy, Simon P Harding, Chris A Rogers, et al.
Health Technology Assessment (Winchester, England)|June 16, 2021
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCTPhilip Hykin, A Toby Prevost, Sobha Sivaprasad, et al.
Ophthalmology Science|July 20, 2026
Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway TrialUsha Chakravarthy, Chui Ming Gemmy Cheung, Giovanni Staurenghi, et al.
Ophthalmology. Retina|August 29, 2020
Patterns and Determinants of Choroidal Thickness in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases StudyYoungseok Song, Yih-Chung Tham, Crystal Chong, et al.
The British Journal of Ophthalmology|August 21, 2017
Evaluation of coronary artery disease as a risk factor for reticular pseudodrusenRachel V McCarter, Gareth J McKay, Nicola B Quinn, et al.
American Journal of Ophthalmology|October 14, 2025
International Consensus and Guidelines on Diagnosing and Managing Pachydrusen from APVRS, AEEC, APOIS, AAPPO, and ARIMariko Sasaki, Rajendra S Apte, Mae-Lynn Catherine Bastion, et al.
The Cochrane Database of Systematic Reviews|September 16, 2014
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationLorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, et al.
Pageof 32